Another publication from today on how far IBX has the opportunity to make progress in many commercial applications. It specifically pointed this quote from Bob Proulx out...
"This is very exciting science. It has long been known that iron oxide nanoparticles create contrast with magnetic resonance imagers".
"We believe that work like that shown in this publication, along with our upcoming study to look at our MagSense nanoparticles for clinical detection of HER2 metastatic breast cancer, will pave the way to multiple commercial opportunities for Imagion and our nanoparticle technology.” Bob Proulx, Executive Chairman of Imagion Biosystems
Market Data 
Markets 
AI
